Dimorphic anemia meaning
dimorphic anemia definition causes peripheral smear

| Cause | Mechanism |
|---|---|
| Sideroblastic anemia (most classic) | Defective heme synthesis produces a mixed population of hypochromic microcytes + normocytic/macrocytic cells. Characteristic ringed sideroblasts seen on bone marrow. Both acquired (MDS) and congenital forms. |
| Iron deficiency responding to iron therapy | After iron supplementation begins, new normochromic cells emerge alongside old hypochromic cells - two populations coexist for weeks |
| Combined iron + B12/folate deficiency | Iron deficiency pushes MCV down; B12/folate deficiency pushes MCV up; peripheral smear shows both microcytes and macrocytes. Classic example: atrophic gastritis causing both blood loss (iron deficiency) and B12 malabsorption. |
| Post-transfusion | Transfused normal donor cells mix with the patient's own hypochromic microcytic cells |
| Lead poisoning | Impairs heme synthesis similarly to sideroblastic anemia |
lap appendectomy signs symptoms
acute appendicitis clinical signs symptoms diagnosis
| Symptom | Details |
|---|---|
| Periumbilical/epigastric pain | Classic early symptom - vague, crampy, colicky. Visceral in origin. |
| Pain migration to RLQ | Most specific symptom (LR+ 2.06). Pain shifts to McBurney's point as parietal peritoneum is involved. |
| Anorexia | Very common; loss of appetite is often an early warning (LR+ 1.27). |
| Nausea and vomiting | Usually follow pain onset - if vomiting precedes pain, think other diagnosis (LR+ 1.63 for vomiting). |
| Fever | Low-grade, rarely above 38.5°C in uncomplicated cases. High fever suggests perforation/abscess. |
| General malaise | Fatigue, feeling unwell. |
| Bowel changes | Diarrhea or constipation may occur; not dominant. |
| Dysuria | Burning with urination possible if appendix lies near ureter or bladder. |
Key rule: Pain BEFORE vomiting = appendicitis. Vomiting BEFORE pain = gastroenteritis.
| Sign | How to Elicit | Significance |
|---|---|---|
| RLQ Tenderness | Direct palpation of RLQ | Most reliable single sign; absent tenderness makes appendicitis less likely |
| McBurney's Sign | Point tenderness at McBurney's point (1/3 distance from ASIS to umbilicus) | Indicates RLQ peritoneal inflammation |
| Rebound Tenderness | Pain worse on sudden release of deep pressure | Peritoneal irritation (LR+ 1.99) |
| Guarding | Voluntary/involuntary abdominal wall contraction | Peritoneal irritation (LR+ 2.48) |
| Percussion Tenderness | Gentle percussion over RLQ causes pain | Highest LR+ at 2.86 |
| Rigidity | Board-like abdominal wall stiffness | Suggests generalized peritonitis |
| Sign | How to Elicit | Implication |
|---|---|---|
| Rovsing's Sign | LLQ palpation causes RLQ pain | Peritoneal irritation in RLQ (sensitivity 30-68%, specificity 58-91%) |
| Psoas Sign | Extension of right hip causes pain | Retrocecal appendix (LR+ 2.31; sensitivity 16-39%) |
| Obturator Sign | Internal rotation of flexed right hip causes RLQ pain | Pelvic appendix (sensitivity 21-34%, specificity 79-96%) |
| Dunphy's Sign | Sharp RLQ pain with coughing | Peritoneal inflammation |
| Heel Drop / Jar test | Pain on heel strike while standing | Peritoneal irritation |
Note: Special signs (Psoas, Obturator, Rovsing's) are specific but not sensitive - their absence does not rule out appendicitis.
| Test | Finding |
|---|---|
| WBC | Leukocytosis (10,000-14,000/mL typical; >18,000 suggests perforation) |
| Neutrophils | Neutrophilia (>75%) - elevated polymorphs |
| CRP | >10 mg/mL suggests acute appendicitis; >50 mg/mL suggests complicated/perforated |
| Urinalysis | May show mild pyuria or hematuria (proximity to ureter); NO bacteria = rules out UTI |
| Pregnancy test | Must be negative in females to exclude ectopic pregnancy |
| Variable | Points |
|---|---|
| Migration of pain to RLQ | 1 |
| Anorexia | 1 |
| Nausea/Vomiting | 1 |
| RLQ tenderness | 2 |
| Rebound tenderness | 1 |
| Elevated temperature (≥37.3°C) | 1 |
| Leukocytosis ≥10,000 | 2 |
| PMN shift (>75% neutrophils) | 1 |
| Total | 10 |
Post op what are the side effects symptoms
laparoscopic appendectomy postoperative complications side effects recovery
https://pmc.ncbi.nlm.nih.gov/articles/PMC11512652
| Symptom | Why It Happens | Duration |
|---|---|---|
| Abdominal pain at incision sites | 3 small port-site wounds healing | 3-7 days; managed with oral analgesics |
| Shoulder tip pain | Residual CO2 gas used to inflate abdomen rises and irritates the diaphragm (referred via phrenic nerve) | 24-48 hours; resolves as gas absorbs |
| Abdominal bloating/distension | Residual gas in peritoneal cavity | 1-3 days |
| Nausea and vomiting | General anesthesia effect; post-op ileus | 24-48 hours |
| Fatigue and weakness | Physiological stress response to surgery and anesthesia | Days to 1-2 weeks |
| Mild fever (< 38°C) | Normal inflammatory response to surgical trauma | Up to 48 hours post-op |
| Constipation or altered bowel habits | Anesthesia slows gut motility; reduced oral intake | First few days |
| Port-site bruising/swelling | Trocar insertion trauma | 5-7 days |
| Sore throat | Endotracheal intubation during anesthesia | 1-2 days |
| Complication | Signs/Symptoms | Notes |
|---|---|---|
| Surgical Site Infection (SSI) | Redness, warmth, swelling, pus, fever at port sites | Most common complication overall (~75% of all complications); higher risk in perforated appendicitis |
| Intra-abdominal abscess | Persistent or worsening abdominal pain, spiking fever, raised WBC, not recovering as expected | Particularly common after perforated appendicitis (up to 7% need percutaneous drainage) |
| Paralytic ileus | Absent bowel sounds, abdominal distension, no passage of flatus/stool, nausea/vomiting | Usually resolves with conservative management |
| Bleeding / hematoma | Increasing abdominal pain, dropping blood pressure, bruising around port sites | Rare; may need re-operation |
| Bowel injury (unrecognized) | Worsening abdominal pain, distension, fever, elevated WBC after day 1-2 | Bowel injury during laparoscopy must be ruled out in anyone with unexpected post-op pain - plain X-ray may show ileus or free air |
| Urinary retention | Inability to urinate post-op | Common with spinal/general anesthesia; usually self-limiting |
| Appendix stump leak | Peritonitis signs - diffuse tenderness, fever, sepsis | Rare but serious; if staple/clip fails at stump |
| Complication | Signs/Symptoms |
|---|---|
| Port-site hernia | Bulge at trocar site, discomfort, may become obstructed |
| Adhesion-related bowel obstruction | Crampy abdominal pain, vomiting, inability to pass stool/gas |
| Pulmonary embolism (PE) | Sudden shortness of breath, chest pain, tachycardia |
| Chronic port-site pain | Persistent discomfort at trocar sites |
| Parameter | Laparoscopic Appendectomy |
|---|---|
| Hospital stay | 24-36 hours (uncomplicated) |
| Return to full activity | ~2 weeks |
| Overall complication rate | ~5.5% (uncomplicated appendicitis) |
| Mortality (uncomplicated) | ~0.09% |
| Complication rate (perforated) | 12-25% |
| Mortality (perforated, elderly >70 yrs) | Up to 32% |
Pablocicilib and anastrozole epidemiology and risk at what age and which drug would most likely cause pneumonitis
palbociclib pneumonitis interstitial lung disease
palbociclib anastrozole pneumonitis incidence risk age epidemiology breast cancer
PMID: 37994878
CDK4/6 inhibitor palbociclib interstitial lung disease incidence
PMID: 40142360
PMID: 33939324
https://pmc.ncbi.nlm.nih.gov/articles/PMC7392360
PMID: 39123221
| Parameter | Detail |
|---|---|
| Target population | Postmenopausal women with HR+/HER2- breast cancer |
| Typical age at treatment | 50-70+ years (postmenopausal) |
| Median age in trials | ~62-65 years (PALOMA trials) |
| Breast cancer age peak | HR+ breast cancer incidence rises sharply after age 50; most metastatic patients are in their 60s |
| Male use | Approved in males with HR+/HER2- advanced breast cancer (rare, ~1% of BC) |
| Feature | Data |
|---|---|
| Incidence in clinical trials | Underreported - pneumonitis was not captured as a primary endpoint in PALOMA trials; real-world rates appear higher than trial data |
| Real-world incidence | ~2.1% in a 2025 multicenter study (464 patients, Turkey) [PMID: 40142360] |
| Mean age of affected patients | 62.5 ± 9.85 years (range typically 51-89 years) [PMID: 40142360] |
| Onset timing | Median 53 days (~38 days IQR) from treatment initiation [PMID: 33939324] |
| Typical CT patterns | Hypersensitivity pneumonitis, NSIP (nonspecific interstitial pneumonia), ground-glass opacities, interlobular septal thickening, bilateral infiltrates |
| Severity | Grade 3 in most cases; Grade 4 in ~20%; fatal cases reported (1 death in the 2025 study) |
| Presenting symptoms | Worsening dyspnea (can start as early as 3 months post-initiation), dry cough, hypoxia |
| Drug | Primary Toxicity Profile | ILD/Pneumonitis Signal |
|---|---|---|
| Palbociclib | Highest hematologic toxicity (neutropenia), fatigue, alopecia | ILD signal present but lower ROR vs. abemaciclib |
| Ribociclib | QT prolongation, hepatotoxicity, macrocytosis | ILD + pneumonitis shared signal |
| Abemaciclib | Diarrhea, GI toxicity, highest ILD/pneumonitis signal | Highest ROR for ILD among the three |
Key finding: Abemaciclib actually carries the highest ILD signal among CDK4/6 inhibitors. Palbociclib does cause ILD, but its strongest toxicity signature is myelosuppression (neutropenia). Abemaciclib has specific ILD/interstitial lung disease as its distinguishing pulmonary risk.
| Question | Answer |
|---|---|
| Which drug causes pneumonitis? | Palbociclib (CDK4/6 inhibitor) - anastrozole does not |
| Most ILD-prone CDK4/6 inhibitor? | Abemaciclib has the highest ILD signal; palbociclib's dominant toxicity is neutropenia |
| Age at risk? | Mean ~62-65 years (postmenopausal women); ILD observed across 51-89 age range |
| Incidence | ~2.1% real-world; onset typically within 53 days of starting treatment |
| Pattern | Hypersensitivity pneumonitis, NSIP - bilateral ground-glass opacities on CT |